AVADEL PHARMACEUTICALS PLC — Revenue by Fiscal Year
16 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/4372d318-36de-4ece-8051-c04a3edec90b/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2024 | $169.1M | 2024-01-01 – 2024-12-31 | evidence 0001012477-25-000010 |
| FY 2023 | $28.0M | 2023-01-01 – 2023-12-31 | evidence 0001012477-24-000008 |
| FY 2022 | $0 | 2022-01-01 – 2022-12-31 | evidence 0001012477-23-000009 |
| FY 2021 | $0 | 2021-01-01 – 2021-12-31 | evidence 0001012477-22-000004 |
| FY 2020 | $22.3M | 2020-01-01 – 2020-12-31 | evidence 0001012477-21-000004 |
| FY 2019 | $59.2M | 2019-01-01 – 2019-12-31 | evidence 0001012477-20-000007 |
| FY 2018 | $103.3M | 2018-01-01 – 2018-12-31 | evidence 0001012477-19-000002 |
| FY 2017 | $173.2M | 2017-01-01 – 2017-12-31 | evidence 0001012477-19-000002 |
| FY 2016 | $150.2M | 2016-01-01 – 2016-12-31 | evidence 0001012477-19-000002 |
| FY 2015 | $173.0M | 2015-01-01 – 2015-12-31 | evidence 0001012477-17-000021 |
| FY 2014 | $15.0M | 2014-01-01 – 2014-12-31 | evidence 0001012477-17-000021 |
| FY 2013 | $4.2M | 2013-01-01 – 2013-12-31 | evidence 0001144204-15-026535 |
| FY 2012 | $7.5M | 2012-01-01 – 2012-12-31 | evidence 0001144204-15-026535 |
| FY 2011 | $32.6M | 2011-01-01 – 2011-12-31 | evidence 0001144204-12-024442 |
| FY 2010 | $37.1M | 2010-01-01 – 2010-12-31 | evidence 0001144204-12-024442 |
| FY 2009 | $42.1M | 2009-01-01 – 2009-12-31 | evidence 0001144204-12-024442 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
AVADEL PHARMACEUTICALS PLC — all facts · Net Income · Operating Income